Address And Details

255 Liberty Street , New York, NY 10286
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The Fund seeks long-term capital growth consistent with the preservation of capital; current income is a secondary goal.To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in the common stock of U.S. and foreign companies. The fund focuses on "blue chip" multinational companies with total market values of more than $5 billion. These are large, established, globally managed companies that manufacture and distribute their products and services throughout the world.In choosing stocks, the fund's portfolio managers first identify economic sectors that they believe will expand over the next three to five years or longer. Using fundamental analysis, the fund's portfolio managers then seek companies within these sectors that have demonstrated sustained patterns of profitability, strong balance sheets, an expanding global presence and the potential to achieve predictable, above-average earnings growth. Under normal circumstances, at least 40% of the fund's assets will be invested in companies that have significant exposure to the economies of countries other than the United States. These are companies that are organized or domiciled in a foreign country or have at least 50% of their assets outside the U.S. or at least 50% of their revenues or profits are from goods produced or sold, investments made, or services performed outside the United States. These companies may be subject to the risks that are involved in investing in foreign securities. The fund also invests in U.S. dollar-denominated American Depositary Receipts (ADRs).The fund employs a "buy-and-hold" investment strategy, which is an investment strategy characterized by a low portfolio turnover rate, which helps reduce the fund's trading costs and minimizes tax liability by limiting the distribution of capital gains.

Net Asset Value

as of 5:43 PM ET 09/22/2021

Performance

  • 1 Week
  • -2.44%
  • 1 Month
  • -1.20%
  • 3 Months
  • +1.99%
  • 1 Yr Return
  • +27.23%
  • 5 Yr Return
  • +45.74%

Equity Sector Breakdown

Technology 30.75%
NonDurables 22.77%
Finance 14.07%
IndustrialCyclical 11.67%
RetailTrade 5.26%
Health 4.19%
Services 2.19%
Energy 1.89%
ConsumerDurables n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 99.54%
ForeignStocks 32.47%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 730.03 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 4.77 2.82 -1.22
Beta 0.87 0.86 0.91
R Squared 0.97 0.91 0.88
Std Deviation 16.36 13.50 12.94
Sharpe Ratio 1.32 1.37 n/a

Purchase Information

as of 5:31 PM ET 09/21/2021
Minimum Initial $1000
Minimum Additional $100
Minimum Initial IRA $750

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +29.21%
  • +40.38%
+29.21% +40.38%
3 Year
  • +21.32%
  • +21.07%
+21.32% +21.07%
10 Year
  • +13.33%
  • +12.30%
+13.33% +12.30%
Life Of Fund
  • +9.92%
  • +9.80%
+9.92% +9.80%

Top 10 Holdings

Symbol Company Name % Of Assets
MSFT MICROSOFT CORP 8.46%
AAPL APPLE INC 6.82%
FB FACEBOOK INC 6.37%
GOOGL ALPHABET INC CLASS A 4.60%
OREP.PA L'OREAL SA 4.58%
LVMUY LVMH 4.52%
V VISA INC 3.70%
ASML ASML HOLDING NV 3.57%
TXN TEXAS INSTRUMENTS INC 3.39%
AMZN AMAZON COM INC 3.21%

Recent Articles from TheStreet

Evergrande Group Lead

Evergrande Quickly Fades From View

With worries about a contagious financial crisis from China easing, Wall Street shifted to the Fed and speculation, James “Rev Shark” Deporre notes.

Novavax Lead

Novavax Stock Surges on Covid-19 Vaccine Application to WHO

Novavax and Serum Institute of India have applied to the WHO for an emergency use listing of Novavax's Covid-19 vaccine.

Why It's Unhealthy to Own Rite Aid, Plus Jim Cramer's Take

Rite Aid Stock Must Hold This Key Support Level After Dip on Earnings

Rite Aid stock has one key support level left before more potential downside. Investors trading the stock should keep that level in mind.

Cannabis Weed Marijuana Federal Lead

U.S. Cannabis Stocks Rise on Effort to Allow Bank Financing

Measure to allow banks to finance the cannabis industry passes voice vote in U.S. House.

Wall Street Lead

Dow Climbs On Fed Tapering Stance; Evergrande Debt In Focus

Stocks surge amid the Fed's patience on tapering and amid cautious optimism for a brokered solution to the Evergrande debt crisis.

Joby Aviation Lead

Air Taxi Maker Joby Aviation Rated Overweight by Morgan Stanley

Joby is 'a first mover to address the urban air mobility market,' which Morgan Stanley sees at $1 trillion in 2040 and $9 trillion in 2050.

Get Excited About Roku: Streaming Content Is Starting to Get Very Interesting

Roku Lifted to Buy; Guggenheim Sees Growth Overseas, Ad Potential

Guggenheim raised Roku to a buy based on the streaming-tech company's growth potential overseas and more potent advertising capabilities.